Replies to post #117759 on Biotech Values

[DewDiligence]

MNTA’s share of the Lovenox collaboration’s profit is 45% (not 50%), so your $150M estimate for the collaboration’s 1Q11 profit would mean $68M (not $75M) for MNTA’s share.

when do you think we get some meaningful update on the FoB and M118 programs?

Pretty soon for the former, IMO.

[10nisman]

So Momenta should get revenue of around $75M with net income close to $45 million.

As Dew already mentioned profit would be $68 million vs. $75 million. Also, MNTA's net income is likely going to be closer to $50 million (using $68 million in mL profit) vs. your $45 million.

FWIW, I expect Q1 mL revenue to be between $210-225 million and MNTA's EPS/share between $0.85 and $0.96.